Glenmark gets CDSCO panel nod to market Remogliflozin, Vildagliptin, Metformin FDC drug Medical Dialogues Team12 Sep 2021 5:30 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark Pha...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Aristo Pharma Medical Dialogues Team3 Sep 2021 12:54 PM GMTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, the National Pharmaceutical Pricing Authority (NPPA) panel has set the pr...
NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma Medical Dialogues Team31 Aug 2021 12:25 PM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the popular antidiabetic Fixed-Dose Combination (FDC) of...
NPPA fixes retail price of 19 formulations including Metformin, Dapagliflozin, Details Medical Dialogues Team27 Aug 2021 8:15 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 11:18 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order (DPCO)...
Single dose of metformin reduces hepatic venous pressure in portal hypertension: Study Dr. Nandita Mohan6 Aug 2021 3:30 AM GMTPortal hypertension is the main determinant of clinical decompensation in patients with liver cirrhosis. In preclinical data metformin lowers portal ...
Metformin decreases risk of basal cell carcinoma: JAAD study Dr Manoj Kumar Nayak2 Aug 2021 6:00 AM GMTMetformin decreases risk of basal cell carcinoma (BCC), finds Study published in Journal of American Academy of Dermatology. Metformin, an...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 12:51 PM GMTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving bene...
Metformin lowers asthma exacerbations independent of blood sugar control: Study Dr. Shravani Dali27 July 2021 4:15 AM GMTUsage of Metformin, irrespective of blood sugar level control and obesity was linked with a lower probability of asthma-associated Emergency...
NPPA fixes price of 14 formulations including Diabetes drugs and antibiotics, Details Medical Dialogues Team20 July 2021 8:01 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha20 July 2021 6:15 AM GMTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to DPP4i...
Liraglutide addition to SGLT2 inhibitors intensifies type 2 diabetes treatment: Study Medha17 July 2021 7:15 AM GMTDelhi: Liraglutide (1.8 mg) seems to be an effective way to intensify the treatment of type 2 diabetes irrespective of BMI, HbA1c, insulin resistance, ...
